Jonathan Davidson

Summary

Publications

  1. ncbi Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Psychopharmacol 26:259-67. 2006
  2. doi Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Trent Drive, 4th Floor, Room 4082B, Durham, NC 27710, USA
    Int Clin Psychopharmacol 23:299-303. 2008
  3. ncbi Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Arch Gen Psychiatry 63:1158-65. 2006
  4. doi Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo
    Jonathan Davidson
    Duke University Medical Center, Durham, NC, USA
    J Psychopharmacol 26:778-83. 2012
  5. ncbi Effects of paroxetine and venlafaxine XR on heart rate variability in depression
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Psychopharmacol 25:480-4. 2005
  6. ncbi Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Trent Drive, Yellow Zone, Box 3812, 4th Floor, Room 4082B, Durham, NC 27710, USA
    J Psychiatr Res 38:497-502. 2004
  7. ncbi Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder
    Jonathan Davidson
    Department of Psychiatry, Duke University Medical Center, Trent Drive, 4th Floor, Room 4082B, Durham, NC 27710, USA
    J Clin Psychopharmacol 24:118-25. 2004
  8. doi Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
    Hum Psychopharmacol 23:519-26. 2008
  9. ncbi A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology
    Samantha Meltzer-Brody
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27955, USA
    Obstet Gynecol 104:770-6. 2004
  10. ncbi Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies
    Dan J Stein
    MRC Unit on Anxiety Disorders, University of Stellenbosch, PO Box 19063, Tygerberg 7505, Cape Town, South Africa
    Expert Opin Pharmacother 4:1829-38. 2003

Detail Information

Publications10

  1. ncbi Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Psychopharmacol 26:259-67. 2006
    ..Mean maximum daily doses were 225-mg venlafaxine ER and 151-mg sertraline. Both treatments were generally well tolerated. Study results suggest that venlafaxine ER is effective and well tolerated in the short-term treatment of PTSD...
  2. doi Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Trent Drive, 4th Floor, Room 4082B, Durham, NC 27710, USA
    Int Clin Psychopharmacol 23:299-303. 2008
    ..The findings suggest that assessment of treatment response might be enhanced by routine evaluation of resilience...
  3. ncbi Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Arch Gen Psychiatry 63:1158-65. 2006
    ..No large-scale posttraumatic stress disorder drug trials have been conducted to evaluate treatment effects beyond 12 weeks outside of those with selective serotonin reuptake inhibitors...
  4. doi Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo
    Jonathan Davidson
    Duke University Medical Center, Durham, NC, USA
    J Psychopharmacol 26:778-83. 2012
    ..Future research may be warranted to explore the relationship between response to active treatment and the spectrum of resiliency...
  5. ncbi Effects of paroxetine and venlafaxine XR on heart rate variability in depression
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Psychopharmacol 25:480-4. 2005
    ..Further comparisons of selective serotonin reuptake inhibitor and serotonin and norepinephrine reuptake inhibitor drugs on HRV are warranted...
  6. ncbi Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Trent Drive, Yellow Zone, Box 3812, 4th Floor, Room 4082B, Durham, NC 27710, USA
    J Psychiatr Res 38:497-502. 2004
    ..Our findings imply that, for patients similar to those in this study, an increase in anger after one week of treatment might be one factor to consider when making a decision about continuation of the medication...
  7. ncbi Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder
    Jonathan Davidson
    Department of Psychiatry, Duke University Medical Center, Trent Drive, 4th Floor, Room 4082B, Durham, NC 27710, USA
    J Clin Psychopharmacol 24:118-25. 2004
    ..We report the results of a multicenter, randomized, placebo-controlled trial comparing the efficacy, safety, and tolerability of fluvoxamine controlled release (CR) to placebo in patients with generalized social anxiety disorder...
  8. doi Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies
    Jonathan Davidson
    Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
    Hum Psychopharmacol 23:519-26. 2008
    ..To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD)...
  9. ncbi A brief screening instrument to detect posttraumatic stress disorder in outpatient gynecology
    Samantha Meltzer-Brody
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27955, USA
    Obstet Gynecol 104:770-6. 2004
    ..Our objectives were 1) to document the prevalence of a trauma history among women seeking routine gynecologic care and 2) to evaluate a 4-item screening instrument for PTSD for triaging women with a trauma history for further evaluation...
  10. ncbi Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies
    Dan J Stein
    MRC Unit on Anxiety Disorders, University of Stellenbosch, PO Box 19063, Tygerberg 7505, Cape Town, South Africa
    Expert Opin Pharmacother 4:1829-38. 2003
    ..The medication is effective in both male and female PTSD patients and whether or not there are comorbid disorders such as depression...